Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.

In Brief Winter 2023

  • Jonathan and Hope Ashner

    Jonathan and Hope Ashner

    A generous $100,000 gift from Jonathan and Hope Ashner was made to support the research of Elizabeth Buchbinder, MD. The gift will help to fuel Buchbinder’s groundbreaking investigations into melanoma and maximize progress against the disease.

    Continue Reading

  • Doron Broman

    Doron Broman

    Doron Broman, a Miami-based real estate developer and stage IV pancreatic cancer patient, has given $150,000 to support research in pancreatic cancer under the direction of Kimmie Ng, MD, MPH. Broman came to Dana-Farber in 2015 with only months to live, but under the treatment of Ng, has defied the odds and is celebrating seven…

    Continue Reading

  • Jeffrey and Jennifer Goldstein

    Jeffrey and Jennifer Goldstein

    Jeffrey and Jennifer Goldstein made a generous gift in support of Pasi Jänne, MD, PhD, director of the Carole M. and Philip L. Lowe Center for Thoracic Oncology at Dana-Farber. The gift will support Jänne and his team’s continued research into targeted therapies in lung cancer, novel EGFR inhibitors, and mechanisms of drug resistance, ultimately…

    Continue Reading

  • Matthew Miller

    Matthew Miller

    Matthew Miller gave $100,000 to advance groundbreaking investigations in melanoma led by Rizwan Haq, MD, PhD. Miller’s support will help Haq uncover the genomic intricacies of drug resistance and explore new ways to enhance personalized medicine for patients.

    Continue Reading

  • National Foundation for Cancer Research

    National Foundation for Cancer Research

    Dana-Farber recently received a $110,000 grant from the National Foundation for Cancer Research to study new, non-invasive approaches to identify specific subtypes of kidney cancer and particular genetic alterations in prostate cancer, with the aim of creating earlier detection and treatment interventions for patients with these diseases.

    Continue Reading

  • Terri Brodeur Breast Cancer Foundation

    Terri Brodeur Breast Cancer Foundation

    The Terri Brodeur Breast Cancer Foundation recently made grants totaling $200,000 to Dana-Farber Cancer Institute to fund two studies. One explores circulating tumor DNA at critical timepoints in early stage hormone receptor-positive breast cancer, and the second assesses how chemotherapy effects the tumor-immune microenvironment and estrogen receptor activity in young women with hormone receptor-positive breast…

    Continue Reading